Delivery Order SPE2DB20D1100-SPE2DB22FC6Q4
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product, with a potential value of $135,712.32 and a completion date of June 30, 2023. This delivery order is part of Amerisourcebergen's existing indefinite delivery contract with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 ml vials. The total potential value of the award is $128,918.52, with a completion date of October 15, 2021. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 mL vials. The order has a potential value of $218,619.00 and a completion date of September 28, 2022. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order is...
- This is a $23,118.08 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OCREVUS 300 mg/10 ml vials. The contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp, operating out of its corporate office in Conshohocken, Pennsylvania, has received numerous federal contracts from DLA to supply pharmaceuticals and medical supplies in support of military...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 MG/10 ML VIAL 10ML. The delivery order has a potential value of $109,309.50 and a completion date of March 3, 2022. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceutical products...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product, with a potential value of $109,309.50 and a completion date of March 3, 2022. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract awards from DLA to supply pharmaceuticals,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, with a potential value of $113,093.60, is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a completion date of May 9, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides pharmaceutical products and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order, with a potential value of $131,171.40, is for 300 mg/10 ml vials of the drug OCREVUS. The order was placed against an existing contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $196,757.10 firm fixed price delivery order is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a completion date of June 7, 2022 and was awarded on May 16, 2022. Amerisourcebergen Drug Corp, through its...
- This is a $109,309.50 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 300 mg/10 ml vials of the pharmaceutical product OCREVUS. The delivery order was placed against an existing contract vehicle, with no set-aside designation. AmerisourceBergen Drug Corp, as the prime contractor, will provide the pharmaceutical products to support...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB22FC6Q4Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of pharmaceutical products. Specifically, the order is for OCREVUS 300 MG/10 ML VIAL 10ML, a specialty medication. The firm fixed price delivery order has a potential value of $196,757.10 and a completion date of August 12, 2022. No set-aside designation was used. AmerisourceBergen Drug Corp, operating out of its corporate office in Conshohocken, Pennsylvania, has a history of providing pharmaceuticals and medical supplies to support DLA Troop Support Medical programs and facilities. The company also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $196.8k | 7/22/22 |